The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype
Open accessAbstract
Recently, cancer has been considered to be a complex system that includes the tumor microenvironment (TME). Tumor-associated macrophages (TAMs) are the most common immune-related stromal cells in the TME, and communication between cancer cells and TAMs is crucial for the progression of epithelial ovarian cancer (EOC). In this study, we revealed that exosomes derived from EOC cells remodel macrophages to a tumor-promoted phenotype, namely TAMs. In addition, hypoxic microenvironments have been postulated to facilitate this process in the TME, and hypoxia-inducible factors (HIFs) play an important role in this process. We found that TAMs educated by hypoxic exosomes derived from EOC cells promote tumor proliferation and migration in a feedback loop. Based on microarray analysis of normoxic and hypoxic exosomes, we discovered that a panel of miRNAs was enriched in hypoxic exosomes. And these three highly expressed miRNAs were induced by hypoxia via HIFs. In this study, we revealed that under hypoxic conditions, EOC cell-derived exosomes deliver miRNAs to induce M2 macrophage polarization, which promotes EOC cell proliferation and migration. This study suggests that these exosomes and associated miRNAs might serve as targets for novel treatments or diagnostic biomarkers for EOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Su, S., Liu, Q., Chen, J., Chen, J., Chen, F., He, C., Huang, D., Wu, W., Lin, L., Huang, W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.021 · Cited by 772
Cancer statistics for Hispanics/Latinos, 2012
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21153 · Cited by 655
Hsu, Y.-L., Hung, J.-Y., Chang, W.-A., Lin, Y.-S., Pan, Y.-C., Tsai, P.-H., Wu, C.-Y., & Kuo, P.-L. (2017) · Oncogene · doi:10.1038/onc.2017.105 · Cited by 597
Self-citationLevels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
Bos, R., Zhong, H., Hanrahan, C. F., Mommers, E. C. M., Semenza, G. L., Pinedo, H. M., Abeloff, M. D., Simons, J. W., van Diest, P. J., & van der Wall, E. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.309 · Cited by 593
Li, L., Li, C., Wang, S., Wang, Z., Jiang, J., Wang, W., Li, X., Chen, J., Liu, K., Li, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1625 · Cited by 532
Self-citationCancer statistics for Hispanics/Latinos, 2015
Siegel, R. L., Fedewa, S. A., Miller, K. D., Goding‐Sauer, A., Pinheiro, P. S., Martinez‐Tyson, D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21314 · Cited by 468
Inhibitors of Cytokine Signal Transduction
Wormald, S., & Hilton, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r300030200 · Cited by 440
Biswas, S. K., Sica, A., & Lewis, C. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2011 · Cited by 435
Yin, M., Li, X., Tan, S., Zhou, H. J., Ji, W., Bellone, S., Xu, X., Zhang, H., Santin, A. D., Lou, G., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87252 · Cited by 417
Self-citationChallagundla, K. B., Wise, P. M., Neviani, P., Chava, H., Murtadha, M., Xu, T., Kennedy, R., Ivan, C., Zhang, X., Vannini, I., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv135 · Cited by 359
Ying, X., Wu, Q., Wu, X., Zhu, Q., Wang, X., Jiang, L., Chen, X., & Wang, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9246 · Cited by 348
Self-citationThe Promise of Targeting Macrophages in Cancer Therapy
Brown, J. M., Recht, L., & Strober, S. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-3122 · Cited by 321
Cytokine receptor signaling through the Jak–Stat–Socs pathway in disease
O'Sullivan, L. A., Liongue, C., Lewis, R. S., Stephenson, S. E. M., & Ward, A. C. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.11.025 · Cited by 308
Anti‐tumour strategies aiming to target tumour‐associated macrophages
Tang, X., Mo, C., Wang, Y., Wei, D., & Xiao, H. (2013) · Immunology · doi:10.1111/imm.12023 · Cited by 278
JAKs, STATs and Src kinases in hematopoiesis
Rane, S. G., & Reddy, E. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205398 · Cited by 242
Choi, K. M., Kashyap, P. C., Dutta, N., Stoltz, G. J., Ordog, T., Shea Donohue, T., Bauer, A. J., Linden, D. R., Szurszewski, J. H., Gibbons, S. J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.014 · Cited by 233
Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression
Liu, J., Zhang, C., Zhao, Y., Yue, X., Wu, H., Huang, S., Chen, J., Tomsky, K., Xie, H., Khella, C. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01947-w · Cited by 213
Acs, G., Zhang, P. J., McGrath, C. M., Acs, P., McBroom, J., Mohyeldin, A., Liu, S., Lu, H., & Verma, A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64314-3 · Cited by 193
Komohara, Y., Hirahara, J., Horikawa, T., Kawamura, K., Kiyota, E., Sakashita, N., Araki, N., & Takeya, M. (2006) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6871.2006 · Cited by 172
Evolution of JAK-STAT Pathway Components: Mechanisms and Role in Immune System Development
Liongue, C., O’Sullivan, L. A., Trengove, M. C., & Ward, A. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032777 · Cited by 171
Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells
Desir, S., Dickson, E. L., Vogel, R. I., Thayanithy, V., Wong, P., Teoh, D. G. K., Geller, M. A., Steer, C. J., Subramanian, S., & Lou, E. (2016) · Oncotarget · doi:10.18632/oncotarget.9504 · Cited by 151
Zhang, J., Cao, J., Ma, S., Dong, R., Meng, W., Ying, M., Weng, Q., Chen, Z., Ma, J., Fang, Q., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1856 · Cited by 144
Green, C. E., Liu, T., Montel, V., Hsiao, G., Lester, R. D., Subramaniam, S., Gonias, S. L., & Klemke, R. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006713 · Cited by 135
Lord, M. S., Jung, M., Teoh, W. Y., Gunawan, C., Vassie, J. A., Amal, R., & Whitelock, J. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.024 · Cited by 134
Leblond, M. M., Gérault, A. N., Corroyer‐Dulmont, A., MacKenzie, E. T., Petit, E., Bernaudin, M., & Valable, S. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1056442 · Cited by 118
Nanomedicine Strategies to Target Tumor-Associated Macrophages
Binnemars‐Postma, K., Storm, G., & Prakash, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050979 · Cited by 115
Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer
Seo, E. J., Kim, D. K., Jang, I. H., Choi, E. J., Shin, S., Lee, S. I., Kwon, S., Kim, K., Suh, D., & Kim, J. H. (2016) · Oncotarget · doi:10.18632/oncotarget.10954 · Cited by 109
The emerging roles and therapeutic potential of exosomes in epithelial ovarian cancer
Li, X., & Wang, X. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0659-y · Cited by 106
Self-citationRegulation of the expression of ICAM-1 on human monocytes and monocytic tumor cell lines
Möst, J., Schwaeble, W., Drach, J. W., Sommerauer, A., & Dierich, M. P. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.6.1635 · Cited by 98
Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression
Rupaimoole, R., Ivan, C., Yang, D., Gharpure, K. M., Wu, S. Y., Pecot, C. V., Previs, R. A., Nagaraja, A. S., Armaiz-Peña, G. N., McGuire, M. H., et al. (2016) · Oncogene · doi:10.1038/onc.2015.492 · Cited by 95
Knowles, H. J., Mole, D. R., Ratcliffe, P. J., & Harris, A. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2351 · Cited by 94
Lee, J., Lee, G. T., Woo, S. H., Ha, Y., Kwon, S. J., Kim, W., & Kim, I. Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4563 · Cited by 93
Chen, P., Cheng, H., Wang, J. C. K., Wang, S.-W., Tai, H., Lin, C., & Tang, C. (2014) · Oncotarget · doi:10.18632/oncotarget.1570 · Cited by 87
Wang, X., Deavers, M. T., Patenia, R. S., Bassett, R. L., Mueller, P., Ma, Q., Wang, E., & Freedman, R. S. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-30 · Cited by 83
Self-citationRe: Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
Costa, A., Coradini, D., Carrassi, A., Erdas, R., Sardella, A., & Daidone, M. G. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.15.1175-a · Cited by 83
Cavnar, M. J., Turcotte, S., Katz, S. C., Kuk, D., Gönen, M., Shia, J., Allen, P. J., Balachandran, V. P., D'Angelica, M. I., Kingham, T. P., et al. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-5812-8 · Cited by 73
Microvesicles as Potential Ovarian Cancer Biomarkers
Giusti, I., D’Ascenzo, S., & Dolo, V. (2013) · BioMed Research International · doi:10.1155/2013/703048 · Cited by 65
Joshi, S., Kumar, S., Ponnusamy, M. P., & Batra, S. K. (2016) · Oncogene · doi:10.1038/onc.2016.119 · Cited by 52
Wang, R., Zhang, T., Ma, Z., Wang, Y., Cheng, Z., Xu, H., Li, W., & Wang, X. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.02.015 · Cited by 39
Self-citationOmichi, C., Nakamura, K., Haraga, J., Masuyama, H., & Hiramatsu, Y. (2016) · Cancer Medicine · doi:10.1002/cam4.681 · Cited by 24
CRISPR/Cas9-mediated ASXL1 mutations in U937 cells disrupt myeloid differentiation
Wu, Z., Zhao, X., Banaszak, L. G., Gutierrez‐Rodrigues, F., Keyvanfar, K., Gao, S., Raffo, D. Q., Kajigaya, S., & Young, N. S. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4290 · Cited by 12
Wei, L., Yin, F., Zhang, W., & Li, L. (2017) · Medicine · doi:10.1097/md.0000000000006345 · Cited by 9
Cited by
Context-specific regulation of extracellular vesicle biogenesis and cargo selection
Dixson, A. C., Dawson, T. R., Di Vizio, D., & Weaver, A. M. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00576-0 · Cited by 791
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 563
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
Liang, Y., Song, X., Li, Y., Chen, B., Zhao, W., Wang, L., Zhang, H., Liu, Y., Han, D., Zhang, N., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01206-5 · Cited by 373
Self-citationRetractedExtracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy
Xie, F., Zhou, X., Fang, M., Li, H., Su, P., Tu, Y., Zhang, L., & Zhou, F. (2019) · Advanced Science · doi:10.1002/advs.201901779 · Cited by 327
Xu, Z., Chen, Y., Ma, L., Chen, Y., Liu, J., Guo, Y., Yu, T., Zhang, L., Zhu, L., & Shu, Y. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.046 · Cited by 319
Metadata
- Authors
- Chen, X., Zhou, J., Li, X., Wang, X., Lin, Y., & Wang, X.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 435
- Pages
- 80-91
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2887549163
- Cited by
- 287
- References
- 44
- FWCI
- 9.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.